6/17/2016

Chloroquine Tablets

Products Affected - Description

- Chloroquine oral tablet, Ranbaxy, 250 mg, bottle, 50 count, NDC 63304-0460-50
- Chloroquine oral tablet, Ranbaxy, 500 mg, bottle, 25 count, NDC 63304-0461-26
- Chloroquine oral tablet, West-Ward, 500 mg, bottle, 25 count, NDC 00143-2125-22

Reason for the Shortage

- Global Pharmaceuticals discontinued chloroquine tablets in 2014.
- Rising has chloroquine tablets available.
- Ranbaxy has chloroquine tablets on shortage due to third party supply issues.
- West-Ward is not actively marketing chloroquine tablets.

Available Products

- Chloroquine tablet, Rising Pharmaceuticals, 250 mg, 50 count, NDC 64980-0177-50
- Chloroquine tablet, Rising Pharmaceuticals, 500 mg, 25 count, NDC 64980-0178-02

Estimated Resupply Dates

- Ranbaxy has chloroquine tablets on long-term back order and the company cannot estimate a release date.
- Rising has chloroquine tablets readily available.

Updated

Updated June 17, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 21, 2015 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.